Table 2.
Characteristics of patients with male breast cancer from literature.
| Study | Study years | No. of patients | Mean age | Type (%) | Size (range) | Grade (%) | ER | PR | HER2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Years (range) | IDC | DCIS | Other | T1 | T2 | T3 | 1 | 2 | 3 | n(%) | n(%) | n(%) | ||
| Port et al11 | 1996.9-1999.12 | 16 | 57.2(36-70) | 14 | 1 | 1 | 1.3 cm(0.1-3) | 0 | 6(37.5) | 5(31.25) | 14(87.5) | - | - | ||
| Albo et al12 | 1999.10-2020.10 | 7 | 61.1(44-76) | 7 | 0 | 0 | 1.94 cm(0.5-3.8) | 0 | 5(71.4) | 2(28.6) | 7(100) | 1(14.2) | 3(42.9) | ||
| Goyal et al13 | 1998.2-2003.10 | 9 | 70(26-79) | 9 | 0 | 0 | 4(44) | 5(56) | 0 | 1(11) | 8(89) | 0 | - | - | - |
| Cimmino et al14 | 1998.5-2002.11 | 6 | 59.8(51-67) | 4 | 1 | 1 | 1.6 cm(0.7-2.8) | 1(16.7) | 3(50) | 1(16.7) | 4(66.7) | - | - | ||
| Cicco et al15 | 1999.3-2003.5 | 18 | 59(46-80) | 11 | 2 | 5 | 16(88.9) | 2(11.1) | 0 | - | - | - | 18(100) | 15(83.3) | - |
| Rusby et al16 | 1996.5-2006.10 | 31 | 62(24-86) | 26 | 2 | 3 | 19(61) | 12(39) | 0 | 2(6) | 18(58) | 11(35) | 29(100) | 28(97) | 5(19) |
| Boughey et al17 | 1999-2005 | 30 | 62.5(44-80) | 25 | 3 | 2 | 16(53.3) | 10(33.3) | 0 | 0 | 17(56.7) | 13(43.3) | 29(96.7) | 23(76.7) | 3(10) |
| Gentilini et al18 | 1999.4-2005.1 | 32 | 58(33-80) | 23 | 3 | 6 | 23(71.9) | 3(9.4) | - | 11(34.4) | 21(65.6) | 31(96.9) | 25(78.1) | 5(15.6) | |
| Flynn et al19 | 1996.9-2005.7 | 78 | 60.1(23-84) | 65 | 10 | 3 | 1.9 cm(0.1-5.3) | - | - | - | 64(98.5) | - | - | ||
| Eryilmaz et al20 | 1994-2010 | 25 | 67(38-83) | 22 | 1 | 2 | 5(20) | 19(76) | 1(4) | - | - | - | 15(60) | 10(40) | 2(8) |
| Maraz et al21 | 2004.1-2013.8 | 16 | 64.5(47-76) | 13 | 0 | 3 | 1.9cm(0.5-3.5) | 2(12.5) | 11(68.75) | 3(18.75) | 15(94) | - | 16(100) | ||
| Simsek et al22 | 2009.2-2012.1 | 10 | 57.2(34-85) | - | - | - | 2.2cm(1.0-4.0) | - | - | - | - | - | - | ||
| Total | 278 | 61.2* | 219(82) | 23(9) | 26(10) | 17(12) | 78(53) | 46(31) | 226(87) | 102(71) | 34(24) | ||||
*Age was shown as a weighted mean.
Abbreviations: ER: estrogen receptor; PR: progesterone receptor; IDC: invasive ductal carcinoma; DCIS: ductal carcinoma in situ.